Central IRB Services for NIAID Coronavirus COVID-19 OWS ACTIV-3 Clinical Trial

NIH RePORTER · NIH · N02 · $718,961 · view on reporter.nih.gov ↗

Abstract

The purpose of this funding is to provide the Central Institutional Review Board (IRB) services for the Coronavirus COVID-19 ACTIV-3 trial.

Key facts

NIH application ID: 10274221
Project number: 272201500015I-0-759302000017-3
Recipient: MEDICAL SCIENCE & COMPUTING, LLC
Principal Investigator: ANNA MAHYERA
Activity code: N02
Funding institute: NIH
Fiscal year: 2020
Award amount: $718,961
Award type: —
Project period: 2020-03-30 → 2021-03-29